Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASP.L Regulatory News (ASP)

  • There is currently no data for ASP

Acquisition

26 Sep 2008 07:00

RNS Number : 3765E
Ascribe plc
26 September 2008
 



Press Release

26 September 2008

Ascribe plc

("Ascribe" or "the Group")

Ascribe acquires healthcare division of WCI Consulting Ltd.

Ascribe (AIM:ASP), the health IT Group, is pleased to announce the acquisition of WCI Consulting Ltd's healthcare division ("WCI Healthcare"). WCI Healthcare has over 20 years' experience in delivering high quality consultancy and implementation resource to the NHS and offers a wide range of professional services. Ascribe will benefit from the expertise of over 30 trained members of staff joining from WCI Healthcare, who will help to deliver integrated IT solutions from the Group's growing sales pipeline.

The WCI Healthcare team are experts in project implementation, particularly providing integration and consultancy expertise for larger enterprise wide solutions. They are currently working with Connecting for Health and BT, as well as having contracts with local NHS Trusts.

Under the terms of the agreement, Ascribe has acquired the trade and assets of WCI Healthcare for a cash consideration of £650k payable on completion with a further £300k deferred consideration paid in twelve months subject to certain performance criteria. The assets being acquired will be determined from accounts prepared after completion. For the year ended 31 December 2007, the Board estimates WCI Healthcare delivered a pre-tax profit of approximately £263,000, on sales of approximately £3.5m, excluding £200,000 of allocated central costs not required post acquisition.

Commenting on the acquisition, Stephen Critchlow, Executive Chairman of Ascribe plc, said: "We are delighted that WCI Healthcare has become part of the Ascribe group. We will now be able to offer consultancy and integration services to our customers, further enabling us to improve information provided at the point of care. This will extend the offering to our customers as they implement systems locally."

- ENDS -

For further information please contact:

Ascribe plc

Stephen Critchlow, Executive Chairman 

stephen.critchlow@ascribe.com

Tel: : +44 (0) 870 053 4545

www.ascribe.com

Jeremy Lee, Finance Director

jeremy.lee@ascribe.com

Tel: : +44 (0) 870 053 4545

www.ascribe.com

Investment enquiries:

Cenkos

Ivonne Cantu

icantu@cenkos.com

Tel: +44 (0) 20 7397 8900

www.cenkos.com

Media enquiries:

Abchurch

Stephanie Cuthbert / Justin Heath

Tel: +44 (0) 20 7398 7718

stephanie.cuthbert@abchurch-group.com

www.abchurch-group.com 

Notes to Editors

Ascribe plc is a leading healthcare company that develops and markets software solutions that support patient, clinical and business processes to Primary & Secondary healthcare providers in the UK and overseas. 

Ascribe is committed to providing technologies that improve patient safety standards and the company's solutions directly improve patient care and deliver financial savings to customers. The Group sells directly to hospitals and Primary Care Trusts and has also been awarded framework agreements by the ASCC on behalf of Connecting for Health (CfH).

The Group provides solutions to health organisations and clinical professionals in all healthcare sectors; customers include Emergency and Minor Injuries Units, Mental Health and Social Care Units, Hospitals requiring patient administration systems (PAS) and medical equipment management, Hospital and Retail Pharmacies, and General Practice surgeries. Offering patient and decision support information to these clinicians in context with their activity is the key to the company's ongoing success.

Ascribe plc was floated on AIM in 2004, and will now employ over 265 personnel through its operating companies in the UKKenyaAustralia and New Zealand. For more information, please visit www.ascribe.com.

© Ascribe 2008. Ascribe is a registered trademark of Ascribe plc. All other brands and product names and trademarks are the registered property of their respective companies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFKPKQFBKDBCB
Date   Source Headline
1st Jun 20219:49 amRNSUpdate on TIDM Code
1st Jun 20217:00 amRNSAdmission to Main Market
27th Jan 200911:45 amRNSPosting of re-registration circular
21st Jan 20097:30 amRNSOffer Unconditional in all Respects
8th Jan 20097:00 amRNSOffer update
7th Jan 20091:14 pmRNSHolding(s) in Company
5th Jan 20096:08 pmRNSGeneral Meeting & Recommended Cash Offer
18th Dec 20083:55 pmRNSAnnual Report and Accounts
17th Dec 20088:00 amRNSRecommended Cash Offer
10th Dec 200812:42 pmRNSResult of AGM
17th Nov 20087:00 amRNSDirector/PDMR Shareholding
10th Oct 200810:45 amRNSRule 8.3- Ascribe PLC
3rd Oct 200812:09 pmRNSRule 8.3- Ascribe PLC
1st Oct 20087:00 amRNSFinal Results
26th Sep 20087:00 amRNSAcquisition
3rd Sep 20089:06 amRNSExercise of Options
21st Aug 200811:39 amRNSRule 8.3- Ascribe Plc
19th Aug 20088:19 amRNSAnnouncement regarding possib
22nd Jul 20087:00 amRNSTrading Update
8th May 20087:01 amRNSASCC Framework Agreement
14th Apr 20084:29 pmRNSHolding(s) in Company
2nd Apr 20088:00 amRNSInstallement of Web Pharmacy
12th Mar 20087:01 amRNSInterim Results
15th Feb 20082:55 pmRNSIssue of Equity
4th Feb 20089:57 amRNSIssue of Equity
23rd Jan 20087:01 amRNSTrading Statement
21st Jan 20084:54 pmRNSIssue of Equity
7th Dec 200711:23 amRNSHolding(s) in Company
6th Dec 20075:28 pmRNSHolding(s) in Company
29th Nov 200711:29 amRNSDirector/PDMR Shareholding
31st Oct 200711:23 amRNSTrading update &Result of AGM
29th Oct 20073:24 pmRNSHolding(s) in Company
26th Oct 200711:29 amRNSHolding(s) in Company
25th Oct 20074:06 pmRNSDirector/PDMR Shareholding
25th Oct 200711:31 amRNSIssue of Equity
22nd Oct 20071:35 pmRNSIssue of Equity
22nd Oct 200712:40 pmRNSAcquisition
5th Oct 20079:09 amRNSHolding(s) in Company
25th Sep 20072:50 pmRNSHolding(s) in Company
19th Sep 20077:01 amRNSFinal Results
4th Sep 20077:00 amRNSNotice of Results
17th Aug 20075:30 pmRNSAIM Rule 26
17th Aug 20074:53 pmRNSAIM Rule 26 Information
15th Aug 20072:00 pmRNSHolding(s) in Company
9th Aug 20075:57 pmRNSHolding(s) in Company
30th Jul 20072:40 pmRNSIssue of Equity
24th Jul 20077:00 amRNSTrading Update
16th Jul 20075:19 pmRNSHolding(s) in Company
16th Jul 20077:00 amRNSDirectorate Change
8th Jun 20072:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.